glp-1 receptor agonists energy fatigue effects 2025 Frontiers Do GLP-1 Medications Make You

Akkermansia muciniphila is a beneficial gut microorganism associated with maintaining the intestinal mucus layer and supporting gut barrier health

In PIONEER 6 trial, 3183 patients with T2DM were randomized to either oral semaglutide or placebo were observed for cardiovascular events up to a median of approximately 16 months

Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses

and Wonderly, Lauren, "Association of Glucagon-Like Peptide-1 Receptor Agonist Treatment with Perioperative and Postoperative Complications in Patients Undergoing Elective Bariatric Surgery" (2024)

Gastric emptying was assessed 2 days pre-treatment and 24 h after the dose at day 2, day 30, and day 79

In some animal experiments, it has been reported that GLP-1 may be effective in improving inflammation [27,28], postprandial hyperlipidemia [29,30], endothelial cell dysfunction [31], and oxidative stress [32], as well as protecting -cells [33,34]